152 related articles for article (PubMed ID: 33081555)
1. Using electronic health record data to identify comparator populations for comparative effectiveness research.
Ramsey SD; Adamson BJ; Wang X; Bargo D; Baxi SS; Ghosh S; Meropol NJ
J Med Econ; 2020 Dec; 23(12):1618-1622. PubMed ID: 33081555
[TBL] [Abstract][Full Text] [Related]
2. Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record-Derived Real-World Data.
Tan K; Bryan J; Segal B; Bellomo L; Nussbaum N; Tucker M; Torres AZ; Bennette C; Capra W; Curtis M; Miksad RA
Clin Pharmacol Ther; 2022 Jan; 111(1):168-178. PubMed ID: 34197637
[TBL] [Abstract][Full Text] [Related]
3. From real-world electronic health record data to real-world results using artificial intelligence.
Knevel R; Liao KP
Ann Rheum Dis; 2023 Mar; 82(3):306-311. PubMed ID: 36150748
[TBL] [Abstract][Full Text] [Related]
4. Real-world data: towards achieving the achievable in cancer care.
Booth CM; Karim S; Mackillop WJ
Nat Rev Clin Oncol; 2019 May; 16(5):312-325. PubMed ID: 30700859
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.
Khozin S; Abernethy AP; Nussbaum NC; Zhi J; Curtis MD; Tucker M; Lee SE; Light DE; Gossai A; Sorg RA; Torres AZ; Patel P; Blumenthal GM; Pazdur R
Oncologist; 2018 Mar; 23(3):328-336. PubMed ID: 29317551
[TBL] [Abstract][Full Text] [Related]
6. Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
Griffith SD; Tucker M; Bowser B; Calkins G; Chang CJ; Guardino E; Khozin S; Kraut J; You P; Schrag D; Miksad RA
Adv Ther; 2019 Aug; 36(8):2122-2136. PubMed ID: 31140124
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative assessment of real world data comparative effectiveness research of systemic therapies in lung oncology: A systematic review.
Peters BJM; Janssen VEMT; Schramel FM; van de Garde EMW
Cancer Epidemiol; 2016 Oct; 44():5-15. PubMed ID: 27449577
[TBL] [Abstract][Full Text] [Related]
8. Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
Khozin S; Carson KR; Zhi J; Tucker M; Lee SE; Light DE; Curtis MD; Bralic M; Kaganman I; Gossai A; Hofmeister P; Torres AZ; Miksad RA; Blumenthal GM; Pazdur R; Abernethy AP
Oncologist; 2019 May; 24(5):648-656. PubMed ID: 30591549
[TBL] [Abstract][Full Text] [Related]
9. Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research.
Lin KJ; Glynn RJ; Singer DE; Murphy SN; Lii J; Schneeweiss S
Epidemiology; 2018 May; 29(3):356-363. PubMed ID: 29283893
[TBL] [Abstract][Full Text] [Related]
10. Data quality considerations for evaluating COVID-19 treatments using real world data: learnings from the National COVID Cohort Collaborative (N3C).
Sidky H; Young JC; Girvin AT; Lee E; Shao YR; Hotaling N; Michael S; Wilkins KJ; Setoguchi S; Funk MJ;
BMC Med Res Methodol; 2023 Feb; 23(1):46. PubMed ID: 36800930
[TBL] [Abstract][Full Text] [Related]
11. Challenges in and Opportunities for Electronic Health Record-Based Data Analysis and Interpretation.
Kim MK; Rouphael C; McMichael J; Welch N; Dasarathy S
Gut Liver; 2024 Mar; 18(2):201-208. PubMed ID: 37905424
[TBL] [Abstract][Full Text] [Related]
12. Differential frequency in imaging-based outcome measurement: Bias in real-world oncology comparative-effectiveness studies.
Adamson BJS; Ma X; Griffith SD; Sweeney EM; Sarkar S; Bourla AB
Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):46-54. PubMed ID: 34227170
[TBL] [Abstract][Full Text] [Related]
13. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Patorno E; Gopalakrishnan C; Franklin JM; Brodovicz KG; Masso-Gonzalez E; Bartels DB; Liu J; Schneeweiss S
Diabetes Obes Metab; 2018 Apr; 20(4):974-984. PubMed ID: 29206336
[TBL] [Abstract][Full Text] [Related]
14. CER Hub: An informatics platform for conducting comparative effectiveness research using multi-institutional, heterogeneous, electronic clinical data.
Hazlehurst BL; Kurtz SE; Masica A; Stevens VJ; McBurnie MA; Puro JE; Vijayadeva V; Au DH; Brannon ED; Sittig DF
Int J Med Inform; 2015 Oct; 84(10):763-73. PubMed ID: 26138036
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC.
Ma X; Bellomo L; Magee K; Bennette CS; Tymejczyk O; Samant M; Tucker M; Nussbaum N; Bowser BE; Kraut JS; Bourla AB
Adv Ther; 2021 Apr; 38(4):1843-1859. PubMed ID: 33674928
[TBL] [Abstract][Full Text] [Related]
16. Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform.
Bourla AB; Meropol NJ
Digit Health; 2021; 7():20552076211059975. PubMed ID: 34868623
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.
Griffith SD; Miksad RA; Calkins G; You P; Lipitz NG; Bourla AB; Williams E; George DJ; Schrag D; Khozin S; Capra WB; Taylor MD; Abernethy AP
JCO Clin Cancer Inform; 2019 Aug; 3():1-13. PubMed ID: 31403818
[TBL] [Abstract][Full Text] [Related]
18. Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies.
Hernandez-Boussard T; Monda KL; Crespo BC; Riskin D
J Am Med Inform Assoc; 2019 Nov; 26(11):1189-1194. PubMed ID: 31414700
[TBL] [Abstract][Full Text] [Related]
19. The SAFER guides: empowering organizations to improve the safety and effectiveness of electronic health records.
Sittig DF; Ash JS; Singh H
Am J Manag Care; 2014 May; 20(5):418-23. PubMed ID: 25181570
[TBL] [Abstract][Full Text] [Related]
20. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
Mullins CD; Sanchez RJ
J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
